Phaos Technology Holdings (Caym (AMEX: POAS) Stock Competitors & Peer Comparison
See POAS's competitors and their performance on the AMEX and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for POAS and its AMEX peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| POAS | $0.75 | +3.00% | 648.9K | -2.63 | -$0.27 | N/A |
| ABT | $110.51 | +0.53% | 191.2B | 21.21 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $102.79 | +0.97% | 131.5B | 18.59 | $5.53 | +2.77% |
| SYK | $325.73 | -0.04% | 124B | 24.33 | $13.39 | +1.08% |
| BSX | $44.02 | +2.97% | 63.8B | 14.20 | $3.10 | N/A |
| EW | $104.71 | +2.52% | 60.4B | 38.79 | $2.70 | N/A |
| GEHC | $84.03 | +2.00% | 38B | 17.15 | $4.90 | +0.17% |
| DXCM | $81.07 | +2.09% | 30.2B | 31.78 | $2.55 | N/A |
| PHG | $30.79 | +1.45% | 30.1B | 17.60 | $1.75 | +3.20% |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
POAS vs ABT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ABT has a market cap of 191.2B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ABT trades at $110.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ABT's P/E ratio is 21.21. In terms of profitability, POAS's ROE is -3.64%, compared to ABT's ROE of +0.09%. Regarding short-term risk, POAS is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
POAS vs BSX-PA Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, POAS's ROE is -3.64%, compared to BSX-PA's ROE of +0.14%. Regarding short-term risk, POAS is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for POAS.Check BSX-PA's competition here
Medtronic Plc (NYSE: MDT)
POAS vs MDT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, MDT has a market cap of 131.5B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while MDT trades at $102.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas MDT's P/E ratio is 18.59. In terms of profitability, POAS's ROE is -3.64%, compared to MDT's ROE of +0.11%. Regarding short-term risk, POAS is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for POAS.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
POAS vs SYK Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SYK has a market cap of 124B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SYK trades at $325.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SYK's P/E ratio is 24.33. In terms of profitability, POAS's ROE is -3.64%, compared to SYK's ROE of +0.16%. Regarding short-term risk, POAS is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for POAS.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
POAS vs BSX Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BSX has a market cap of 63.8B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BSX trades at $44.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BSX's P/E ratio is 14.20. In terms of profitability, POAS's ROE is -3.64%, compared to BSX's ROE of +0.14%. Regarding short-term risk, POAS is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for POAS.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
POAS vs EW Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, EW has a market cap of 60.4B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while EW trades at $104.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas EW's P/E ratio is 38.79. In terms of profitability, POAS's ROE is -3.64%, compared to EW's ROE of +0.10%. Regarding short-term risk, POAS is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for POAS.Check EW's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
POAS vs GEHC Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, GEHC has a market cap of 38B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while GEHC trades at $84.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas GEHC's P/E ratio is 17.15. In terms of profitability, POAS's ROE is -3.64%, compared to GEHC's ROE of +0.16%. Regarding short-term risk, POAS is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for POAS.Check GEHC's competition here
DexCom, Inc. (NASDAQ: DXCM)
POAS vs DXCM Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, DXCM has a market cap of 30.2B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while DXCM trades at $81.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas DXCM's P/E ratio is 31.78. In terms of profitability, POAS's ROE is -3.64%, compared to DXCM's ROE of +0.37%. Regarding short-term risk, POAS is more volatile compared to DXCM. This indicates higher risk in terms of short-term price fluctuations for POAS.Check DXCM's competition here
Koninklijke Philips N.V. (NYSE: PHG)
POAS vs PHG Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, PHG has a market cap of 30.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while PHG trades at $30.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas PHG's P/E ratio is 17.60. In terms of profitability, POAS's ROE is -3.64%, compared to PHG's ROE of +0.08%. Regarding short-term risk, POAS is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for POAS.Check PHG's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
POAS vs ZBH Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ZBH has a market cap of 20.7B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ZBH trades at $108.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ZBH's P/E ratio is 12.78. In terms of profitability, POAS's ROE is -3.64%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, POAS is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
POAS vs ABMD Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ABMD's P/E ratio is 65.36. In terms of profitability, POAS's ROE is -3.64%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, POAS is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ABMD's competition here
Glaukos Corporation (NYSE: GKOS)
POAS vs GKOS Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, GKOS has a market cap of 14.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while GKOS trades at $238.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas GKOS's P/E ratio is -277.56. In terms of profitability, POAS's ROE is -3.64%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, POAS is more volatile compared to GKOS. This indicates higher risk in terms of short-term price fluctuations for POAS.Check GKOS's competition here
Smith & Nephew plc (NYSE: SNN)
POAS vs SNN Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SNN has a market cap of 13.4B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SNN trades at $31.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SNN's P/E ratio is 20.98. In terms of profitability, POAS's ROE is -3.64%, compared to SNN's ROE of +0.12%. Regarding short-term risk, POAS is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for POAS.Check SNN's competition here
Penumbra, Inc. (NYSE: PEN)
POAS vs PEN Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, PEN has a market cap of 12.7B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while PEN trades at $321.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas PEN's P/E ratio is 84.04. In terms of profitability, POAS's ROE is -3.64%, compared to PEN's ROE of +0.10%. Regarding short-term risk, POAS is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for POAS.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
POAS vs SWAV Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SWAV's P/E ratio is 78.76. In terms of profitability, POAS's ROE is -3.64%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, POAS is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for POAS.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
POAS vs ALGN Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ALGN has a market cap of 12.4B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ALGN trades at $174.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ALGN's P/E ratio is 15.89. In terms of profitability, POAS's ROE is -3.64%, compared to ALGN's ROE of +0.12%. Regarding short-term risk, POAS is more volatile compared to ALGN. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
POAS vs BIO-B Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BIO-B has a market cap of 10.7B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BIO-B trades at $389.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BIO-B's P/E ratio is -68.67. In terms of profitability, POAS's ROE is -3.64%, compared to BIO-B's ROE of +0.14%. Regarding short-term risk, POAS is more volatile compared to BIO-B. This indicates higher risk in terms of short-term price fluctuations for POAS.Check BIO-B's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
POAS vs BIO Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BIO has a market cap of 10.4B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BIO trades at $388.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BIO's P/E ratio is 41.87. In terms of profitability, POAS's ROE is -3.64%, compared to BIO's ROE of +0.14%. Regarding short-term risk, POAS is more volatile compared to BIO. This indicates higher risk in terms of short-term price fluctuations for POAS.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
POAS vs PODD Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, PODD has a market cap of 10.4B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while PODD trades at $149.81.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas PODD's P/E ratio is 25.53. In terms of profitability, POAS's ROE is -3.64%, compared to PODD's ROE of +0.29%. Regarding short-term risk, POAS is more volatile compared to PODD. This indicates higher risk in terms of short-term price fluctuations for POAS.Check PODD's competition here
Globus Medical, Inc. (NYSE: GMED)
POAS vs GMED Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, GMED has a market cap of 10.3B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while GMED trades at $76.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas GMED's P/E ratio is 17.20. In terms of profitability, POAS's ROE is -3.64%, compared to GMED's ROE of +0.12%. Regarding short-term risk, POAS is more volatile compared to GMED. This indicates higher risk in terms of short-term price fluctuations for POAS.Check GMED's competition here
Bruker Corporation (NASDAQ: BRKR)
POAS vs BRKR Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BRKR has a market cap of 10.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BRKR trades at $66.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BRKR's P/E ratio is 33.43. In terms of profitability, POAS's ROE is -3.64%, compared to BRKR's ROE of -0.05%. Regarding short-term risk, POAS is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for POAS.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
POAS vs BRKRP Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BRKRP has a market cap of 10.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BRKRP trades at $484.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BRKRP's P/E ratio is 263.31. In terms of profitability, POAS's ROE is -3.64%, compared to BRKRP's ROE of -0.05%. Regarding short-term risk, POAS is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for POAS.Check BRKRP's competition here
Masimo Corporation (NASDAQ: MASI)
POAS vs MASI Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas MASI's P/E ratio is 44.43. In terms of profitability, POAS's ROE is -3.64%, compared to MASI's ROE of +0.09%. Regarding short-term risk, POAS is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for POAS.Check MASI's competition here
Haemonetics Corporation (NYSE: HAE)
POAS vs HAE Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, HAE has a market cap of 5.4B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while HAE trades at $118.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas HAE's P/E ratio is 23.59. In terms of profitability, POAS's ROE is -3.64%, compared to HAE's ROE of +0.12%. Regarding short-term risk, POAS is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for POAS.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
POAS vs LIVN Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, LIVN has a market cap of 5.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while LIVN trades at $92.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas LIVN's P/E ratio is 21.99. In terms of profitability, POAS's ROE is -3.64%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, POAS is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for POAS.Check LIVN's competition here
Inari Medical, Inc. (NASDAQ: NARI)
POAS vs NARI Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas NARI's P/E ratio is -59.24. In terms of profitability, POAS's ROE is -3.64%, compared to NARI's ROE of -0.00%. Regarding short-term risk, POAS is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for POAS.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
POAS vs ITGR Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ITGR trades at $126.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ITGR's P/E ratio is 19.93. In terms of profitability, POAS's ROE is -3.64%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, POAS is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ITGR's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
POAS vs TMDX Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, TMDX has a market cap of 3.3B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while TMDX trades at $93.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas TMDX's P/E ratio is 47.68. In terms of profitability, POAS's ROE is -3.64%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, POAS is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for POAS.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
POAS vs AXGN Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, AXGN has a market cap of 3B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while AXGN trades at $50.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas AXGN's P/E ratio is 133.18. In terms of profitability, POAS's ROE is -3.64%, compared to AXGN's ROE of -0.11%. Regarding short-term risk, POAS is more volatile compared to AXGN. This indicates higher risk in terms of short-term price fluctuations for POAS.Check AXGN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
POAS vs IRTC Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, IRTC has a market cap of 2.9B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while IRTC trades at $88.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas IRTC's P/E ratio is -206.47. In terms of profitability, POAS's ROE is -3.64%, compared to IRTC's ROE of -0.23%. Regarding short-term risk, POAS is more volatile compared to IRTC. This indicates higher risk in terms of short-term price fluctuations for POAS.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
POAS vs NEOG Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while NEOG trades at $12.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas NEOG's P/E ratio is 43.14. In terms of profitability, POAS's ROE is -3.64%, compared to NEOG's ROE of -0.03%. Regarding short-term risk, POAS is more volatile compared to NEOG. This indicates higher risk in terms of short-term price fluctuations for POAS.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
POAS vs UFPT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, UFPT has a market cap of 2.5B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while UFPT trades at $318.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas UFPT's P/E ratio is 32.55. In terms of profitability, POAS's ROE is -3.64%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, POAS is more volatile compared to UFPT. This indicates higher risk in terms of short-term price fluctuations for POAS.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
POAS vs NUVA Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas NUVA's P/E ratio is 75.00. In terms of profitability, POAS's ROE is -3.64%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, POAS is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for POAS.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
POAS vs ESTA Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ESTA trades at $68.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ESTA's P/E ratio is -54.28. In terms of profitability, POAS's ROE is -3.64%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, POAS is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for POAS.Check ESTA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
POAS vs INSP Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, INSP has a market cap of 1.9B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while INSP trades at $64.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas INSP's P/E ratio is 28.31. In terms of profitability, POAS's ROE is -3.64%, compared to INSP's ROE of +0.12%. Regarding short-term risk, POAS is more volatile compared to INSP. This indicates higher risk in terms of short-term price fluctuations for POAS.Check INSP's competition here
Butterfly Network, Inc. (NYSE: BFLY)
POAS vs BFLY Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BFLY has a market cap of 1.8B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BFLY trades at $6.67.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BFLY's P/E ratio is -27.75. In terms of profitability, POAS's ROE is -3.64%, compared to BFLY's ROE of -0.28%. Regarding short-term risk, POAS is more volatile compared to BFLY. This indicates higher risk in terms of short-term price fluctuations for POAS.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
POAS vs ENOV Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ENOV trades at $28.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ENOV's P/E ratio is 8.17. In terms of profitability, POAS's ROE is -3.64%, compared to ENOV's ROE of -0.36%. Regarding short-term risk, POAS is more volatile compared to ENOV. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ENOV's competition here
CONMED Corporation (NYSE: CNMD)
POAS vs CNMD Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while CNMD trades at $51.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas CNMD's P/E ratio is 11.41. In terms of profitability, POAS's ROE is -3.64%, compared to CNMD's ROE of +0.07%. Regarding short-term risk, POAS is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for POAS.Check CNMD's competition here
Novocure Ltd (NASDAQ: NVCR)
POAS vs NVCR Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, NVCR has a market cap of 1.5B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while NVCR trades at $12.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas NVCR's P/E ratio is -11.80. In terms of profitability, POAS's ROE is -3.64%, compared to NVCR's ROE of -0.36%. Regarding short-term risk, POAS is more volatile compared to NVCR. This indicates higher risk in terms of short-term price fluctuations for POAS.Check NVCR's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
POAS vs LMRI Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, LMRI has a market cap of 1.3B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while LMRI trades at $13.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas LMRI's P/E ratio is -27.01. In terms of profitability, POAS's ROE is -3.64%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, POAS is more volatile compared to LMRI. This indicates higher risk in terms of short-term price fluctuations for POAS.Check LMRI's competition here
Heska Corporation (NASDAQ: HSKA)
POAS vs HSKA Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas HSKA's P/E ratio is -62.49. In terms of profitability, POAS's ROE is -3.64%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, POAS is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for POAS.Check HSKA's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
POAS vs PRCT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, PRCT has a market cap of 1.3B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while PRCT trades at $22.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas PRCT's P/E ratio is -11.52. In terms of profitability, POAS's ROE is -3.64%, compared to PRCT's ROE of -0.33%. Regarding short-term risk, POAS is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for POAS.Check PRCT's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
POAS vs TNDM Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, TNDM has a market cap of 1.3B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while TNDM trades at $18.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas TNDM's P/E ratio is -19.54. In terms of profitability, POAS's ROE is -3.64%, compared to TNDM's ROE of -0.36%. Regarding short-term risk, POAS is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for POAS.Check TNDM's competition here
Avanos Medical, Inc. (NYSE: AVNS)
POAS vs AVNS Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas AVNS's P/E ratio is 27.77. In terms of profitability, POAS's ROE is -3.64%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, POAS is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for POAS.Check AVNS's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
POAS vs SIBN Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SIBN has a market cap of 1.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SIBN trades at $25.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SIBN's P/E ratio is -75.28. In terms of profitability, POAS's ROE is -3.64%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, POAS is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for POAS.Check SIBN's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
POAS vs ATEC Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ATEC has a market cap of 1.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ATEC trades at $7.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ATEC's P/E ratio is -13.11. In terms of profitability, POAS's ROE is -3.64%, compared to ATEC's ROE of -5.47%. Regarding short-term risk, POAS is more volatile compared to ATEC. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ATEC's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
POAS vs IART Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, IART has a market cap of 1.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while IART trades at $14.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas IART's P/E ratio is 6.09. In terms of profitability, POAS's ROE is -3.64%, compared to IART's ROE of +0.01%. Regarding short-term risk, POAS is more volatile compared to IART. This indicates higher risk in terms of short-term price fluctuations for POAS.Check IART's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
POAS vs SILK Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SILK's P/E ratio is -18.96. In terms of profitability, POAS's ROE is -3.64%, compared to SILK's ROE of -0.35%. Regarding short-term risk, POAS is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for POAS.Check SILK's competition here
IRadimed Corporation (NASDAQ: IRMD)
POAS vs IRMD Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while IRMD trades at $86.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas IRMD's P/E ratio is 43.68. In terms of profitability, POAS's ROE is -3.64%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, POAS is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for POAS.Check IRMD's competition here
Paragon 28, Inc. (NYSE: FNA)
POAS vs FNA Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas FNA's P/E ratio is -19.83. In terms of profitability, POAS's ROE is -3.64%, compared to FNA's ROE of -0.35%. Regarding short-term risk, POAS is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for POAS.Check FNA's competition here
CeriBell, Inc. (NASDAQ: CBLL)
POAS vs CBLL Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, CBLL has a market cap of 1.1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while CBLL trades at $27.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas CBLL's P/E ratio is -15.65. In terms of profitability, POAS's ROE is -3.64%, compared to CBLL's ROE of -0.55%. Regarding short-term risk, POAS is more volatile compared to CBLL. This indicates higher risk in terms of short-term price fluctuations for POAS.Check CBLL's competition here
Artivion, Inc. (NYSE: AORT)
POAS vs AORT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, AORT has a market cap of 1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while AORT trades at $20.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas AORT's P/E ratio is 34.38. In terms of profitability, POAS's ROE is -3.64%, compared to AORT's ROE of -0.04%. Regarding short-term risk, POAS is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for POAS.Check AORT's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
POAS vs AHCO Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, AHCO has a market cap of 1B. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while AHCO trades at $7.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas AHCO's P/E ratio is 14.99. In terms of profitability, POAS's ROE is -3.64%, compared to AHCO's ROE of -0.29%. Regarding short-term risk, POAS is more volatile compared to AHCO. This indicates higher risk in terms of short-term price fluctuations for POAS.Check AHCO's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
POAS vs KIDS Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, KIDS has a market cap of 886.5M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while KIDS trades at $33.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas KIDS's P/E ratio is -25.34. In terms of profitability, POAS's ROE is -3.64%, compared to KIDS's ROE of -0.10%. Regarding short-term risk, POAS is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for POAS.Check KIDS's competition here
Picard Medical, Inc. (AMEX: PMI)
POAS vs PMI Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, PMI has a market cap of 851.9M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while PMI trades at $8.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas PMI's P/E ratio is -6.91. In terms of profitability, POAS's ROE is -3.64%, compared to PMI's ROE of -9.31%. Regarding short-term risk, POAS is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for POAS.Check PMI's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
POAS vs CSII Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, CSII has a market cap of 844M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas CSII's P/E ratio is -20.83. In terms of profitability, POAS's ROE is -3.64%, compared to CSII's ROE of -0.14%. Regarding short-term risk, POAS is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for POAS.Check CSII's competition here
Varex Imaging Corporation (NASDAQ: VREX)
POAS vs VREX Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, VREX has a market cap of 783.9M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while VREX trades at $18.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas VREX's P/E ratio is 19.43. In terms of profitability, POAS's ROE is -3.64%, compared to VREX's ROE of +0.05%. Regarding short-term risk, POAS is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for POAS.Check VREX's competition here
InMode Ltd. (NASDAQ: INMD)
POAS vs INMD Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, INMD has a market cap of 776.8M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while INMD trades at $13.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas INMD's P/E ratio is 9.38. In terms of profitability, POAS's ROE is -3.64%, compared to INMD's ROE of +0.12%. Regarding short-term risk, POAS is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for POAS.Check INMD's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
POAS vs CTKB Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, CTKB has a market cap of 764.3M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while CTKB trades at $5.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas CTKB's P/E ratio is -31.15. In terms of profitability, POAS's ROE is -3.64%, compared to CTKB's ROE of -0.25%. Regarding short-term risk, POAS is more volatile compared to CTKB. This indicates higher risk in terms of short-term price fluctuations for POAS.Check CTKB's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
POAS vs BBNX Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BBNX has a market cap of 762.6M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BBNX trades at $16.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BBNX's P/E ratio is -9.21. In terms of profitability, POAS's ROE is -3.64%, compared to BBNX's ROE of -0.27%. Regarding short-term risk, POAS is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for POAS.Check BBNX's competition here
Bioventus Inc. (NASDAQ: BVS)
POAS vs BVS Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BVS has a market cap of 754.2M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BVS trades at $11.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BVS's P/E ratio is 14.49. In terms of profitability, POAS's ROE is -3.64%, compared to BVS's ROE of +0.27%. Regarding short-term risk, POAS is more volatile compared to BVS. This indicates higher risk in terms of short-term price fluctuations for POAS.Check BVS's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
POAS vs PACB Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, PACB has a market cap of 733.6M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while PACB trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas PACB's P/E ratio is -5.76. In terms of profitability, POAS's ROE is -3.64%, compared to PACB's ROE of +6.04%. Regarding short-term risk, POAS is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for POAS.Check PACB's competition here
Delcath Systems, Inc. (NASDAQ: DCTH)
POAS vs DCTH Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, DCTH has a market cap of 704.4M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while DCTH trades at $20.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas DCTH's P/E ratio is 2030.00. In terms of profitability, POAS's ROE is -3.64%, compared to DCTH's ROE of +0.06%. Regarding short-term risk, POAS is less volatile compared to DCTH. This indicates lower risk in terms of short-term price fluctuations for POAS.Check DCTH's competition here
Surmodics, Inc. (NASDAQ: SRDX)
POAS vs SRDX Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SRDX's P/E ratio is -34.66. In terms of profitability, POAS's ROE is -3.64%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, POAS is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for POAS.Check SRDX's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
POAS vs SGHT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SGHT has a market cap of 606M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SGHT trades at $11.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SGHT's P/E ratio is -19.64. In terms of profitability, POAS's ROE is -3.64%, compared to SGHT's ROE of -0.52%. Regarding short-term risk, POAS is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for POAS.Check SGHT's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
POAS vs TCMD Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, TCMD has a market cap of 595.7M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while TCMD trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas TCMD's P/E ratio is 24.62. In terms of profitability, POAS's ROE is -3.64%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, POAS is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for POAS.Check TCMD's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
POAS vs APEN Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas APEN's P/E ratio is -9.43. In terms of profitability, POAS's ROE is -3.64%, compared to APEN's ROE of -0.85%. Regarding short-term risk, POAS is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for POAS.Check APEN's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
POAS vs AVR Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, AVR has a market cap of 578.4M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while AVR trades at $5.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas AVR's P/E ratio is -3.06. In terms of profitability, POAS's ROE is -3.64%, compared to AVR's ROE of -0.78%. Regarding short-term risk, POAS is more volatile compared to AVR. This indicates higher risk in terms of short-term price fluctuations for POAS.Check AVR's competition here
ZimVie Inc. (NASDAQ: ZIMV)
POAS vs ZIMV Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, POAS's ROE is -3.64%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, POAS is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ZIMV's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
POAS vs SENS Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SENS has a market cap of 518.4M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SENS trades at $9.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SENS's P/E ratio is -4.40. In terms of profitability, POAS's ROE is -3.64%, compared to SENS's ROE of -1.66%. Regarding short-term risk, POAS is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for POAS.Check SENS's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
POAS vs NPCE Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, NPCE has a market cap of 449.6M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while NPCE trades at $13.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas NPCE's P/E ratio is -22.98. In terms of profitability, POAS's ROE is -3.64%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, POAS is more volatile compared to NPCE. This indicates higher risk in terms of short-term price fluctuations for POAS.Check NPCE's competition here
Avita Medical Inc. (NASDAQ: RCEL)
POAS vs RCEL Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, RCEL has a market cap of 425.3M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while RCEL trades at $17.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas RCEL's P/E ratio is -11.89. In terms of profitability, POAS's ROE is -3.64%, compared to RCEL's ROE of +1.46%. Regarding short-term risk, POAS is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for POAS.Check RCEL's competition here
Cerus Corporation (NASDAQ: CERS)
POAS vs CERS Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, CERS has a market cap of 417M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while CERS trades at $2.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas CERS's P/E ratio is -68.60. In terms of profitability, POAS's ROE is -3.64%, compared to CERS's ROE of -0.11%. Regarding short-term risk, POAS is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for POAS.Check CERS's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
POAS vs SSII Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SSII has a market cap of 389.9M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SSII trades at $1.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SSII's P/E ratio is -32.42. In terms of profitability, POAS's ROE is -3.64%, compared to SSII's ROE of -0.27%. Regarding short-term risk, POAS is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for POAS.Check SSII's competition here
CapsoVision, Inc. (NASDAQ: CV)
POAS vs CV Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, CV has a market cap of 342.4M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while CV trades at $6.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas CV's P/E ratio is -10.21. In terms of profitability, POAS's ROE is -3.64%, compared to CV's ROE of -1.78%. Regarding short-term risk, POAS is more volatile compared to CV. This indicates higher risk in terms of short-term price fluctuations for POAS.Check CV's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
POAS vs OFIX Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, OFIX has a market cap of 319.3M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while OFIX trades at $7.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas OFIX's P/E ratio is -5.14. In terms of profitability, POAS's ROE is -3.64%, compared to OFIX's ROE of -0.10%. Regarding short-term risk, POAS is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for POAS.Check OFIX's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
POAS vs TMCI Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, TMCI has a market cap of 311.2M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while TMCI trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas TMCI's P/E ratio is -5.09. In terms of profitability, POAS's ROE is -3.64%, compared to TMCI's ROE of -0.76%. Regarding short-term risk, POAS is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for POAS.Check TMCI's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
POAS vs SMLR Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas SMLR's P/E ratio is 3.92. In terms of profitability, POAS's ROE is -3.64%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, POAS is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for POAS.Check SMLR's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
POAS vs CLPT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, CLPT has a market cap of 293.6M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while CLPT trades at $9.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas CLPT's P/E ratio is -7.76. In terms of profitability, POAS's ROE is -3.64%, compared to CLPT's ROE of -1.70%. Regarding short-term risk, POAS is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for POAS.Check CLPT's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
POAS vs INFU Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, INFU has a market cap of 292.6M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while INFU trades at $14.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas INFU's P/E ratio is 35.83. In terms of profitability, POAS's ROE is -3.64%, compared to INFU's ROE of +0.16%. Regarding short-term risk, POAS is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for POAS.Check INFU's competition here
Quantum-Si incorporated (NASDAQ: QSI)
POAS vs QSI Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, QSI has a market cap of 271.6M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while QSI trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas QSI's P/E ratio is -2.97. In terms of profitability, POAS's ROE is -3.64%, compared to QSI's ROE of -0.45%. Regarding short-term risk, POAS is more volatile compared to QSI. This indicates higher risk in terms of short-term price fluctuations for POAS.Check QSI's competition here
Profound Medical Corp. (NASDAQ: PROF)
POAS vs PROF Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, PROF has a market cap of 267.4M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while PROF trades at $7.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas PROF's P/E ratio is -7.47. In terms of profitability, POAS's ROE is -3.64%, compared to PROF's ROE of -0.28%. Regarding short-term risk, POAS is more volatile compared to PROF. This indicates higher risk in terms of short-term price fluctuations for POAS.Check PROF's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
POAS vs MGRM Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas MGRM's P/E ratio is -12.00. In terms of profitability, POAS's ROE is -3.64%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, POAS is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for POAS.Check MGRM's competition here
Electromed, Inc. (AMEX: ELMD)
POAS vs ELMD Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ELMD has a market cap of 224.2M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ELMD trades at $27.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ELMD's P/E ratio is 20.65. In terms of profitability, POAS's ROE is -3.64%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, POAS is more volatile compared to ELMD. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ELMD's competition here
Nevro Corp. (NYSE: NVRO)
POAS vs NVRO Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas NVRO's P/E ratio is -1.91. In terms of profitability, POAS's ROE is -3.64%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, POAS is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for POAS.Check NVRO's competition here
RxSight, Inc. (NASDAQ: RXST)
POAS vs RXST Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, RXST has a market cap of 202.4M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while RXST trades at $4.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas RXST's P/E ratio is -4.31. In terms of profitability, POAS's ROE is -3.64%, compared to RXST's ROE of -0.20%. Regarding short-term risk, POAS is more volatile compared to RXST. This indicates higher risk in terms of short-term price fluctuations for POAS.Check RXST's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
POAS vs TLSI Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, TLSI has a market cap of 198.3M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while TLSI trades at $3.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas TLSI's P/E ratio is -1.92. In terms of profitability, POAS's ROE is -3.64%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, POAS is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for POAS.Check TLSI's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
POAS vs BSGM Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas BSGM's P/E ratio is -5.81. In terms of profitability, POAS's ROE is -3.64%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, POAS is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for POAS.Check BSGM's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
POAS vs MDGS Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas MDGS's P/E ratio is -0.27. In terms of profitability, POAS's ROE is -3.64%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, POAS is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for POAS.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
POAS vs STIM Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, STIM has a market cap of 165.7M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while STIM trades at $2.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas STIM's P/E ratio is -4.94. In terms of profitability, POAS's ROE is -3.64%, compared to STIM's ROE of -1.28%. Regarding short-term risk, POAS is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for POAS.Check STIM's competition here
Inogen, Inc. (NASDAQ: INGN)
POAS vs INGN Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, INGN has a market cap of 162.5M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while INGN trades at $6.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas INGN's P/E ratio is -6.73. In terms of profitability, POAS's ROE is -3.64%, compared to INGN's ROE of -0.20%. Regarding short-term risk, POAS is more volatile compared to INGN. This indicates higher risk in terms of short-term price fluctuations for POAS.Check INGN's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
POAS vs QIPT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas QIPT's P/E ratio is -15.87. In terms of profitability, POAS's ROE is -3.64%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, POAS is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for POAS.Check QIPT's competition here
Quanterix Corporation (NASDAQ: QTRX)
POAS vs QTRX Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, QTRX has a market cap of 159.4M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while QTRX trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas QTRX's P/E ratio is -1.33. In terms of profitability, POAS's ROE is -3.64%, compared to QTRX's ROE of -0.43%. Regarding short-term risk, POAS is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for POAS.Check QTRX's competition here
Owlet, Inc. (NYSE: OWLT)
POAS vs OWLT Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, OWLT has a market cap of 127.4M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while OWLT trades at $4.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas OWLT's P/E ratio is -31.14. In terms of profitability, POAS's ROE is -3.64%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, POAS is more volatile compared to OWLT. This indicates higher risk in terms of short-term price fluctuations for POAS.Check OWLT's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
POAS vs FOCL Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, FOCL has a market cap of 125.9M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while FOCL trades at $3.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas FOCL's P/E ratio is -3.25. In terms of profitability, POAS's ROE is -3.64%, compared to FOCL's ROE of -2.41%. Regarding short-term risk, POAS is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for POAS.Check FOCL's competition here
Pulmonx Corporation (NASDAQ: LUNG)
POAS vs LUNG Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, LUNG has a market cap of 119.8M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while LUNG trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas LUNG's P/E ratio is -2.76. In terms of profitability, POAS's ROE is -3.64%, compared to LUNG's ROE of -0.98%. Regarding short-term risk, POAS is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for POAS.Check LUNG's competition here
iCAD, Inc. (NASDAQ: ICAD)
POAS vs ICAD Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas ICAD's P/E ratio is -20.37. In terms of profitability, POAS's ROE is -3.64%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, POAS is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for POAS.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
POAS vs HJLI Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas HJLI's P/E ratio is N/A. In terms of profitability, POAS's ROE is -3.64%, compared to HJLI's ROE of -0.70%. Regarding short-term risk, POAS is more volatile compared to HJLI. This indicates higher risk in terms of short-term price fluctuations for POAS.Check HJLI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
POAS vs CATX Comparison November 2026
Phaos Technology Holdings (Caym (AMEX: POAS) plays a significant role within the Healthcare sector. Its performance on the AMEX reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, POAS stands at 648.9K. In comparison, CATX has a market cap of 97.7M. Regarding current trading prices, POAS is priced at $0.75 on the AMEX, while CATX trades at $0.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
POAS currently has a P/E ratio of -2.63, whereas CATX's P/E ratio is -0.64. In terms of profitability, POAS's ROE is -3.64%, compared to CATX's ROE of -0.42%. Regarding short-term risk, POAS is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for POAS.Check CATX's competition here